JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2019 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ)
Q4 2019 Results Earnings Conference Call
February 26, 2020, 04:30 PM ET
Company Participants
Katherine Littrell - Vice President, Investor Relations
Bruce Cozadd - Chairman and Chief Executive Officer
Daniel Swisher, Jr. - President and Chief Operating Officer
Robert Iannone - Executive Vice President, Research and Development
Michael Miller - Executive Vice President, U.S. Commercial
Shawn Mindus - Senior Vice President, Financial Planning, Analysis and Strategy
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald
Umer Raffat - Evercore ISI
Gary Nachman - BMO Capital Markets
Gregg Gilbert - SunTrust Robinson Humphrey